Teva Recalls One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes
Anagrelide Teva 0.5mg cps.dur.100
Anagrelide | Uses, Brand Names, Mechanism Of Action
Shire US Inc 54092006301 - McKesson Medical-Surgical
Logo 5240 1 mg Pill White Capsule-shape - Pill Identifier
Anagrelide Teva 0.5mg cps.dur.100
ANAGRELIDE 1 mg Hidrocloruro – Distribuidora Sta María
血小板增多症患者注意！因溶出度测试失败，这批阿那格雷被召回_Teva_批次_降低
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
Anagrelide Hcl Generic Agrylin 0.5 Mg Caps 100 By Teva Pharma
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
These highlights do not include all the information needed to use ANAGRELIDE CAPSULES safely and effectively. See full prescribing information for ANAGRELIDE CAPSULES. ANAGRELIDE capsules, for oral useInitial U.S. Approval: 1997
Teva Anagrelide 0.5mg Capsule
Anagrelide (Atremia) - Uses, Dose, Side effects
Public Assessment Report Decentralised Procedure Anagrelide 0.5 mg hard capsules Anagrelide 1 mg hard capsules (Anagrelide hydro
Teva 00172524060 - McKesson Medical-Surgical
Dissolution Test Failure Prompts Recall of Anagrelide Capsules - MPR
Teva Pharma Recalls One Lot Of Anagrelide Capsules
Anagrelide 0.5mg Capsule
Torrent Pharmaceuticals Recall Anagrelide Capsules over drug's Dissolution test Failure • Drugwatcher.org
